Your browser doesn't support javascript.
loading
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.
Conroy, Thierry; Bosset, Jean-François; Etienne, Pierre-Luc; Rio, Emmanuel; François, Éric; Mesgouez-Nebout, Nathalie; Vendrely, Véronique; Artignan, Xavier; Bouché, Olivier; Gargot, Dany; Boige, Valérie; Bonichon-Lamichhane, Nathalie; Louvet, Christophe; Morand, Clotilde; de la Fouchardière, Christelle; Lamfichekh, Najib; Juzyna, Béata; Jouffroy-Zeller, Claire; Rullier, Eric; Marchal, Frédéric; Gourgou, Sophie; Castan, Florence; Borg, Christophe.
Afiliação
  • Conroy T; Institut de Cancérologie de Lorraine, Université de Lorraine, Nancy, France; APEMAC, Université de Lorraine, Nancy, France. Electronic address: t.conroy@nancy.unicancer.fr.
  • Bosset JF; Hôpital Nord Franche-Comté, Montbéliard, France; University Hospital of Besançon, Besançon, France.
  • Etienne PL; CARIO, Hôpital privé des côtes d'Armor, Plérin, France.
  • Rio E; Institut de Cancérologie de l'Ouest-Site René Gauducheau, Saint-Herblain, France.
  • François É; Centre Antoine Lacassagne, Nice, France.
  • Mesgouez-Nebout N; Institut de Cancérologie de l'Ouest-Site Paul Papin, Angers, France.
  • Vendrely V; Centre Hospitalier et Universitaire de Bordeaux, Hôpital Haut-Lévêque, Pessac, France.
  • Artignan X; Centre Hospitalier Privé Saint-Grégoire, Saint-Grégoire, France.
  • Bouché O; Hôpital Robert Debré, Reims, France.
  • Gargot D; Centre Hospitalier de Blois, Blois, France.
  • Boige V; Gustave Roussy, Villejuif, France.
  • Bonichon-Lamichhane N; Clinique Tivoli, Bordeaux, France.
  • Louvet C; Institut Mutualiste Montsouris, Paris, France.
  • Morand C; Centre Hospitalier Départemental, Site de la Roche-sur-Yon, La Roche-sur-Yon, France.
  • de la Fouchardière C; Centre Léon Bérard, Lyon, France.
  • Lamfichekh N; Hôpital Nord Franche-Comté, Montbéliard, France.
  • Juzyna B; R&D UNICANCER, Paris, France.
  • Jouffroy-Zeller C; R&D UNICANCER, Paris, France.
  • Rullier E; Centre Hospitalier et Universitaire de Bordeaux, Hôpital Haut-Lévêque, Pessac, France.
  • Marchal F; Institut de Cancérologie de Lorraine, Université de Lorraine, Nancy, France.
  • Gourgou S; Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier, France.
  • Castan F; Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier, France.
  • Borg C; Hôpital Nord Franche-Comté, Montbéliard, France; University Hospital of Besançon, Besançon, France.
Lancet Oncol ; 22(5): 702-715, 2021 05.
Article em En | MEDLINE | ID: mdl-33862000
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Protocolos de Quimioterapia Combinada Antineoplásica / Quimiorradioterapia Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Protocolos de Quimioterapia Combinada Antineoplásica / Quimiorradioterapia Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido